Neuroscience
-
The organization of the minimal neuronal substrate capable of generating locomotor rhythmicity in vertebrates is investigated in several species, with an emphasis on identifying evolutionary-conserved features. In lamprey, an eel-like lower vertebrate that swims by undulatory movements of the body, the network has been identified as a recurrent network of excitatory interneurons localized in each spinal hemisegment. This conclusion rested upon the observation that each side of the spinal cord is able to express rhythmic locomotor-related bursting after being surgically separated along the midline, even in the absence of inhibition. ⋯ Moreover, we recorded the output of the unilateral networks in the intact spinal cord (i.e. no midline section performed) by activating them with asymmetrical stimulation. We thus conclude that the lamprey hemicord does possess the intrinsic capability of generating the basic rhythmic drive of locomotion. The wider significance of these data stems from the lamprey being a model of axial locomotion, and from the many lesion studies previously performed in other animals.
-
The ability to rapidly establish a memory link between arbitrary sensory cues and goal-directed movements is part of our daily motor repertoire. It is unknown if this ability is affected by middle cerebral artery stroke. Eighteen right-handed subjects with a first unilateral middle cerebral artery stroke were studied while performing a precision grip to lift objects of different weights. ⋯ The presentation of color cues allowed patients with right hemispheric stroke, but not those with left hemispheric stroke, to scale their grip force according to the weight in the upcoming lift when lifting the weight with the unaffected hand. Color cues did not allow for a predictive scaling of grip force according to the weight of the object to be lifted when lifting with the affected hand, irrespective of the affected hemisphere. These data imply that the ability of visuomotor mapping in the grip-lift task is selectively impaired in the affected hand after right middle cerebral artery stroke, but in both hands after left middle cerebral artery stroke.
-
Stride duration variability is considered a marker of gait balance and can be investigated in at least two different ways. Fluctuation magnitude can be addressed by classical mathematical methods, whereas fluctuation dynamics between strides can be characterized using the autocorrelation function. Although each approach has revealed changes of these parameters in different age-groups, most studies have focused on spontaneous walking speeds, which vary across groups and is described as a possible confounder in the assessment of stride duration variability. ⋯ In contrast, CV was inversely related to walking speed and the age of the subjects. Slower speeds increased CV values, and fluctuation magnitude was also significantly larger for children compared with young and old adults. This confirms that fluctuation magnitude and dynamics could be complementary tools for more complete gait characterization.
-
A compromised protein degradation machinery has been implicated in methamphetamine (MA)-induced neurodegeneration. However, the signaling mechanisms that induce autophagy and ubiquitin-proteasome system (UPS) dysfunction are not well understood. The present study investigates the contributions of protein kinase C delta (PKCδ)-mediated signaling events in MA-induced autophagy, UPS dysfunction, and cell death. ⋯ Notably, rat striatal tissue isolated from MA-treated rats also exhibited elevated LC3-II, ubiquitinated protein levels, and PKCδ cleavage. Taken together, our data demonstrate that MA-induced autophagy serves as an adaptive strategy for inhibiting mitochondria-mediated apoptotic cell death and degradation of aggregated proteins. Our results also suggest that the sustained activation of PKCδ leads to UPS dysfunction, resulting in the activation of caspase-3-mediated apoptotic cell death in the nigrostriatal dopaminergic system.
-
The development of drugs that attenuate neurodegeneration is important for the treatment of Alzheimer's disease (AD). We previously found that smilagenin (SMI), a steroidal sapogenin from traditional Chinese medicinal herbs improves memory in animal models, is neither a cholinesterase inhibitor nor a glutamate receptor antagonist, but can significantly elevate the declined muscarinic receptor (M receptor) density. In this article, to clarify whether SMI represents a new approach for treating neurodegeneration disease, we first demonstrate that SMI pretreatment significantly attenuates the neurodegenerative changes induced by beta amyloid 25-35 (Aβ(25-35)) in cultured rat cortical neurons, including decreased cholinergic neuron number, shortened neurite outgrowth length, and declined M receptor density. ⋯ In the all-trans retinoic acid (RA)-differentiated SH-SY5Y neuroblastoma cells, the BDNF transcription rate measured by a nuclear run-on assay was significantly suppressed by Aβ(25-35) and elevated by SMI, but the BDNF degradation rate measured by half-life determination was unchanged by Aβ(25-35) and SMI. Transcript analysis of the SH-SY5Y cells using quantitative RT-PCR (qRT-PCR) showed that the IV and VI transcripts of BDNF mRNA were significantly decreased by Aβ(25-35) and elevated by SMI. Taken together, we conclude that SMI attenuates Aβ(25-35)-induced neurodegeneration in cultured rat cortical neurons and SH-SY5Y cells mainly through stimulating BDNF mRNA transcription implicating that SMI may represent a novel therapeutic strategy for AD.